[Form 4] Pagaya Technologies Ltd. Insider Trading Activity
Dan Petrozzo, a director of Pagaya Technologies Ltd. (PGY), reported the sale of 2,828 Class A ordinary shares on 09/15/2025. The Form 4 shows the shares were disposed at a weighted average price of $41.4315, and the reporting person retained beneficial ownership of 93,450 shares after the transaction.
The filing discloses the sale was effected pursuant to a 10b5-1 trading plan, and that the individual sale transactions occurred at prices ranging from $39.57 to $41.97. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
- Sale executed under a 10b5-1 plan, indicating the transaction was prearranged and compliant with insider trading rules
- Transparent price disclosure including weighted-average price ($41.4315) and explicit price range ($39.57 to $41.97)
- Filer identified relationship as Director and provided post-transaction beneficial ownership (93,450 shares)
- Insider sale of 2,828 shares may attract investor scrutiny even if planned
- Materiality relative to total outstanding shares not provided, limiting assessment of impact on share supply or ownership percentage
Insights
TL;DR: Director executed a planned sale of 2,828 shares under a 10b5-1 plan; remaining ownership is 93,450 shares.
The transaction is a straightforward insider disposition disclosed on Form 4. The sale was processed under a pre-established 10b5-1 plan, which typically signals a prearranged, rule-compliant liquidity event rather than opportunistic trading. The weighted-average price reported is $41.4315, with actual trade prices between $39.57 and $41.97, which the filer documents and offers to detail if requested. From a market-impact perspective, the size of the sale relative to reported remaining holdings is modest, but materiality relative to total outstanding shares is not disclosed in this filing.
TL;DR: Disclosure follows 10b5-1 and Form 4 requirements; shows proper use of attorney-in-fact signature and price-range disclosure.
The filing demonstrates procedural compliance: the reporter identified relationship to issuer as Director, indicated the sale date, provided a weighted-average price and a range, and included a 10b5-1 plan explanation. The signature by an attorney-in-fact is executed and dated. While insider sales can attract investor attention, this document does not include any non-routine governance concerns or additional contextual information about intent beyond the 10b5-1 statement.